Trial intelligence / Profile preview

Thalidomide in Active Adult Crohn's Disease

NCT02501291Phase 2Completed

Sponsor
The First Affiliated Hospital of Sun Yat-sen University
Start
Jan 2013
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of thalidomide in Crohn's disease, sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Jan 2013; status: completed.

02

Drugs

thalidomide
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT02501291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02501291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call